结构:CC1(C)SC2C(NC(=O)Cc3ccccc3)C(=O)N2C1C(=O)O
HCID2349

Penicillins

3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S334.4 g/molCAS 1406-05-9

IDENTITY

结构与身份

标准 SMILES
CC1(C)SC2C(NC(=O)Cc3ccccc3)C(=O)N2C1C(=O)O
InChIKey
JGSARLDLIJGVTE-UHFFFAOYSA-N
分子式
C16H18N2O4S
平均分子量
334.4 g/mol
单同位素质量
334.09872823

COMPUTED

结构计算性质

已同步
XLogP
1.8
极性表面积
112 Ų
氢键供体
2
氢键受体
5
可旋转键
4
重原子
23
形式电荷
0
复杂度
530

HAZARDS

危害信息

来源:PubChem
Hazards Summary

Occupational asthma reported; [Malo] Allergic contact dermatitis, both immediate and delayed, have been reported in pharmaceutical, healthcare, and animal-care workers. Other sensitizing antibiotics in the penicillin family include benzyl penicillin (54836-26-8), ampicillin (69-53-4), cloxicillin (61-72-3), mezlocilin (51481-65-3), and pivampicillin (33817-20-8). [Kanerva, p. 1189-90]

TOXICITY

毒理信息

来源:PubChem
Adverse Effects

Skin Sensitizer - An agent that can induce an allergic reaction in the skin.;Asthma - Reversible bronchoconstriction (narrowing of bronchioles) initiated by the inhalation of irritating or allergenic agents.

Penicillin V and G can have adverse effects, including nausea, vomiting, diarrhea, rash, abdominal pain, and urticaria. In addition, Penicillin G can have other adverse reactions, including muscle spasms, fever, chills, muscle pain, headache, tachycardia, flushing, tachypnea, and hypotension.;Hypersensitivity reactions: The commonly encountered adverse drug reaction with penicillin is hypersensitivity of immediate onset or delayed onset.;* Immediate onset: This type of reaction occurs within 20 minutes after administering the drug and is characterized by urticaria, pruritis, edema, laryngospasm, bronchospasm, hypotension, vascular collapse, and death.;* Delayed onset: This type of reaction occurs within 1 to 2 weeks of treatment, is rare, and is characterized by fever, malaise, urticaria, myalgia, arthralgia, abdominal pain, and skin rashes.;Gastrointestinal system: Gastrointestinal symptoms, including nausea, vomiting, and stomatitis, were the most commonly reported in over 1% of patients and widely observed with oral administration. Pseudomembranous colitis is also observed during or after the treatment.;Hematologic reactions: If the dose exceeds 10 million units per day and a patient has received a higher dose previously, then those patients can precipitate Coombs-positive hemolytic anemia and neutropenia, resolved when therapy is stopped.;Metabolic reactions: The salt form of penicillin G may cause electrolyte imbalances, such as hyperkalemia, when given IV in a large dose.;Nervous system: Neurological manifestations include hyperreflexia, myoclonic cramps, seizures, and coma after IV doses and are more likely in patients with impaired renal function.;Urogenital system: Urological manifestations with large IV doses include renal tubular damage. Penicillins can also cause acute interstitial nephritis, a disease characterized by inflammation of the tubules and interstitium of the kidneys. Acute interstitial nephritis can also present with hematuria, fever, and rash. The recommendation is to withdraw the drug as the disease could lead to renal failure.;Other reactions: Jarisch- Herxheimer reaction is precipitated when penicillin is administered in patients with syphilis due to rapid lysis of spirochetes and release of endotoxins. Procaine reactions (1 in 500 patients) are due to immediate toxic reactions to procaine due to large single-dose administration. Procaine may cause a pseudoanaphylactic reaction. Procaine can also cause methemoglobinemia.;Drug-Drug Interactions;* Concurrent sulfonamides, erythromycin, and chloramphenicol (bacteriostatic drugs) should be avoided due to antagonistic effects.;* Tubular secretion of penicillin G is blocked by probenecid- higher and longer plasma concentrations are achieved. Probenecid also decreases the volume of distribution of penicillin.;* Drugs such as aspirin, phenylbutazone, sulfonamides, indomethacin, thiazide, furosemide, and ethacrynic acid increase the half-life of penicillin by competing with tubular secretion.

Toxicity Summary

Signs and Symptoms of Overdose;Penicillin has a small risk of toxicity. Clinicians can administer penicillin at relatively high doses compared to other drugs without harming patients. Estimates are that it would take 5 g/kg body weight IV to cause convulsions in a patient. However, penicillin can cause local toxicity due to high-dose injections at sensitive sites such as the eye's anterior chamber or the subarachnoid space. Reports show that pure preparations of penicillin cause no harm to the lungs and veins. Other reports indicate that topical penicillin can prevent coagulation in dental cavities.;Management of Overdose;Neurotoxicity of penicillin requires discontinuation of the offending penicillin. Penicillins are hypothesized to have an inhibitory effect on GABA transmission; consequently, IV benzodiazepines and electroencephalogram (EEG) monitoring may be necessary in refractory cases.

Drug Induced Liver Injury

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

PENICILLIN

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

PHARMACOLOGY

药理信息

来源:PubChem
MeSH Pharmacological Classification

Substances that inhibit the growth or reproduction of BACTERIA.

USES

用途与制造

来源:PubChem
Uses

Use (kg) in USA (2002): 102000;Consumption (g per capita) in the USA (2002): 0.362;Calculated removal (%): 22.6

Use Classification

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

ALIASES

名称与别名

41
CHEBI:17334penicillinsPenicillin AntibioticsAntibiotics, PenicillinRefChem:126139DTXSID501017130215-794-61406-05-9PenicillinCillin7005-30-3Benzopenicillin(5S)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidBenzylpenicillin GFree benzylpenicillin(Phenylmethyl)penicillin3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidPenicillinic acid, benzyl-1232134-74-5(Phenylmethyl)penicillinic acid

REACTIONS

参与反应

2
HRID284835

Training data from https://doi.org/10.1039/C8SC04228D (8/10)

作为生成物、反应物
HRID 284835 方程式

Training data from https://doi.org/10.1039/C8SC04228D (8/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID1133621

Training data from https://doi.org/10.1039/C8SC04228D (7/10)

作为反应物
HRID 1133621 方程式

Training data from https://doi.org/10.1039/C8SC04228D (7/10) · 10.1039/C8SC04228D

查看条件与参与物